Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2026-07-31EMA Withdrawn: Qoyvolma (ustekinumab) — Celltrion Healthcare Hungary Kft.
The EMA has withdrawn Qoyvolma (ustekinumab) from the market.
-
CLINICAL_TRIALS withdrawal · 2026-01-09Clinical Trial Update: Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis [Phase 2]
Phase 2 clinical trial Mini-MARVEL evaluating a mitochondrial antioxidant therapy for ulcerative colitis has been withdrawn.
-
EMA withdrawal · 2025-12-18EMA Withdrawn: Absimky (ustekinumab) — Accord Healthcare S.L.U.
EMA has withdrawn Absimky (ustekinumab) from Accord Healthcare S.L.U., affecting its use for Crohn disease and ulcerative colitis.
-
CLINICAL_TRIALS withdrawal · 2025-12-17Clinical Trial Update: VE202 in Patients With Mild-to-Moderate Ulcerative Colitis [Phase 2]
A Phase 2 trial of VE202 in Ulcerative Colitis has been terminated.
-
EMA withdrawal · 2025-09-08EMA Withdrawn: Eksunbi (ustekinumab) — Samsung Bioepis NL B.V.
The EMA has withdrawn Eksunbi (ustekinumab) from the European market as of 23 May 2025, affecting indications for Crohn's disease, ulcerativ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-08-12Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis [Phase 3]
A Phase 3 clinical trial of mesalamine capsules in children aged 5 to 17 with ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-14Clinical Trial Update: Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating empagliflozin as adjuvant therapy for ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-09Clinical Trial Update: Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway [NA]
Clinical trial evaluating an inflammatory bowel disease biologic care pathway to improve patient outcomes has been withdrawn. The study targ…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis
A non-interventional pilot trial examining the role of gut flora in ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-04Clinical Trial Update: Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis
A ClinicalTrials.gov entry for a study to identify predictors and biomarkers of response to Ozanimod in ulcerative colitis has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: 90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients [NA]
The clinical trial investigating 90Second IBD for improving self-efficacy and quality of life in Crohn's disease and ulcerative colitis has …
-
CLINICAL_TRIALS withdrawal · 2024-10-18Clinical Trial Update: A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis [Phase 1]
A Phase 1b proof-of-concept trial evaluating FE 999322 and FE 999324 in adults with mild to moderate ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study [Phase 4]
ULTRAZ, a Phase 4 trial evaluating leukocyte trafficking after Zeposia (ozanimod) treatment in ulcerative colitis, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-04-18Clinical Trial Update: SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery [Phase 3]
A Phase 3 trial assessing aspirin versus standard of care for VTE prophylaxis after IBD surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-02-01Clinical Trial Update: Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis [Phase 4]
Phase 4 trial evaluating berberine to maintain remission in ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-05-06Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis [Phase 3]
Phase 3 study of mirikizumab in ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-10-27Clinical Trial Update: Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study [Phase 4]
Phase 4 post-marketing study of Vedolizumab-4002 investigating drug–drug interactions has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-01-18Clinical Trial Update: Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD [Phase 4]
A phase 4 clinical trial investigating escalating adalimumab for prevention of relapse in inflammatory bowel disease has been withdrawn.
-
EMA withdrawal · 2019-03-06EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH
The EMA withdrew Cyltezo (adalimumab) from Boehringer Ingelheim International GmbH, affecting multiple indications including hidradenitis su…
-
EMA withdrawal · 2019-03-05EMA Withdrawn: Solymbic (adalimumab) — Amgen Europe B.V.
Solymbic (adalimumab) has been withdrawn from the market by Amgen Europe B.V.
-
CLINICAL_TRIALS withdrawal · 2017-02-07Clinical Trial Update: Lactobacillus GG in Pediatric Ulcerative Colitis (UC) [Phase 2]
Phase 2 trial of Lactobacillus GG for pediatric ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-23Clinical Trial Update: Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease [Phase 2]
Phase 2 trial comparing subcutaneous versus intravenous vedolizumab in ulcerative colitis and Crohn's disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-24Clinical Trial Update: Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
The trial evaluating genetic markers as predictors of Crohn's disease phenotypes in pediatric-onset cases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: Ulcerative Colitis and Vitamin D Supplementation [Phase 1, Phase 2]
A clinical trial evaluating vitamin D supplementation for ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)
A clinical trial (P08166) sponsored by Merck Sharp & Dohme LLC for Crohn's disease and ulcerative colitis has been withdrawn.